BE-RELACs-Trial: Biomarkers Explaining RELevance of ACute Rejections
Read time: 1 mins
Last updated:8th Aug 2012
To explore a number of biomarkers from plasma, serum and renal tissue to describe the impact of different strategies for immunosuppression (Belatacept, Cyclosporine) on the immune-system that may explain differences in long-term outcome.
|Study start date||2012-08-08|